Kelly Spill, a New Jersey mom, received a life-changing cancer diagnosis shortly after giving birth, at the age of 28. Initially, her symptoms were attributed to postpartum issues, but she soon noticed weight loss, fatigue, and loss of appetite, leading her to suspect cancer. After a colonoscopy confirmed that she had stage 3 colorectal cancer, Spill’s biggest fear was not being able to have more children, especially with her newborn son, Chase Bonito, just a month old.
Upon consulting various hospitals for treatment options, Kelly Spill and her family settled on Memorial Sloan Kettering Cancer Center in New York, where they felt most comfortable. The initial treatment plan involving chemotherapy, radiation, and surgery presented a bleak reality for Spill, as it would likely impair her ability to conceive another child at such a young age. Understanding the potential impact of cancer treatments on fertility is crucial for women facing a similar situation, as they can affect reproductive organs and hormone levels.
Before starting chemotherapy, Kelly Spill was offered an unexpected opportunity to participate in a new clinical trial testing an immunotherapy drug called dostarlimab. This innovative treatment route activated her immune system to fight cancer cells and appeared to be less harsh on her body compared to traditional chemotherapy. Immunotherapy has shown significant advancements in cancer treatment, although individual response rates can vary due to factors such as age, lifestyle, and existing medical conditions.
With the decision to undergo the clinical trial, Kelly Spill became the fourth participant in the country, receiving dostarlimab infusions every three weeks for six months. Despite the possibility of side effects, she only dealt with mild fatigue, mainly attributed to motherhood. Over the course of treatment, Spill witnessed her tumor shrink by half and eventually disappear by the ninth session, marking a significant milestone in her battle against cancer.
After being declared cancer-free, Kelly Spill and her husband decided to wait two years before attempting to have another child as a precautionary measure. During this time, she underwent emotional intelligence courses to help her cope with her experience and evolve as a person. In July 2023, she welcomed a healthy baby girl named Maya Grace, bringing a renewed sense of hope and joy to their family. Spill continues to undergo regular scans and check-ups to monitor her health and has plans for a possible third child in the future.
For others facing a cancer diagnosis, Kelly Spill emphasizes the importance of acknowledging and processing their feelings while navigating the challenges of treatment and recovery. Her advice includes seeking emotional support, staying informed about treatment options, and discussing fertility preservation with healthcare providers. Sharing her story serves as a reminder that resilience and hope can triumph over adversity, inspiring others to persevere in the face of life’s obstacles.
